This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2001-2005.
Company Filing History:
Years Active: 2001-2005
Title: Walter C. Soeller: Innovator in Genetic Engineering
Introduction
Walter C. Soeller is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of genetic engineering, particularly in the development of transgenic animal models and methods for modulating biological functions.
Latest Patents
Walter C. Soeller holds 2 patents that showcase his innovative work. His latest patents include "Modulating Ramp Activity," which provides genetically-modified non-human mammals and animal cells containing disrupted RAMP1, RAMP2, or RAMP3 genes. This invention also outlines methods for screening agents that modulate the activity or expression of a RAMP, as well as methods for treating mammals to modulate liver function and muscle metabolism. Another significant patent is for "Transgenic Animal Models for Type II Diabetes Mellitus." This patent describes the generation of transgenic animal models for testing various treatments of Type II Diabetes Mellitus. The DNA construct allows pancreatic β cell-specific expression of human islet associated polypeptide (IAPP) under the regulation of the rat insulin II promoter in both cell lines and transgenic animals.
Career Highlights
Walter C. Soeller is currently associated with Pfizer Corporation, where he continues to advance his research and innovations. His work has been instrumental in understanding and developing treatments for complex diseases.
Collaborations
Throughout his career, Walter has collaborated with esteemed colleagues, including John D. McNeish and John F. Thompson. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Walter C. Soeller is a distinguished inventor whose work in genetic engineering has paved the way for advancements in medical research and treatment. His innovative patents and collaborations reflect his commitment to improving health outcomes through scientific discovery.